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Abstract We report the identification of a gene, named SLC- 
11, encoding a novel G protein-coupled receptor (GPCR). A 
customized search procedure of a database of expressed sequence 
tags (dbEST) retrieved a human cDNA sequence that partially 
encoded a GPCR. A genomic DNA fragment identical to the 
cDNA was obtained and used to screen a library to isolate the 
fuIMength coding region of the gene. This gene was intronless in 
its open reading frame, and encoded a receptor of 402 amino 
acids, and shared -40% amino acid identity in the transmem- 
brane (TM) regions to the five known human somatostatin 
receptors. Northern blot analysis revealed that SLC-1 is 
expressed in human brain regions, including the forebrain and 
hypothalamus. Expression in the rat was highest in brain, 
followed by heart, kidney, and ovary. Expression of SLC-1 in 
COS-7 cells failed to show specific binding to radiolabelled 
Tyrl-somatostatin-14, naloxone, bremazocine, 1,3-di(2-tolyl)- 
guanidine (DTG), or haloperidol. A repeat polymorphism of the 
form (CA)n was discovered in the 5'-untrauslated region (UTR) 
of the gene and SLC-1 was mapped to chromosome 22, q13.3. 
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other subtypes may yet be identified. In searching a database 
of EST cDNAs for sequences encoding GPCRs, we identified 
a fragment with significant homology to the SSTRs. We iso- 
lated this novel gene encoding a receptor elated to the soma- 
tostatin receptor family, with highest expression in the human 
forebrain and hypothalamus. 
2. Material and methods 
2.1. Searching the database of expressed sequence tags (dbEST) 
We queried the dbEST maintained by the National Center for Bio- 
technology Information (NCBI), with the complete amino acid se- 
quence of GPCRs, such as the c~-adrenoceptor, using the TBLASTN 
algorithm [6]. EST sequences that were returned having statistically 
significant scores were examined further. The conceptualized amino 
acid sequences of the EST sequences were used to query [7,8] our 
GPCR database using the FastA algorithm to determine whether 
the EST cDNAs represented known GPCRs [9]. The amino acid se- 
quences thus filtered were used to query the SwissProt (release 31) 
database using the FastA algorithm (BLOSUM 50 matrix, ktup = 1) 
[7,8]. The sequence of one EST (clonelD: c-lzfl0; GenBank Acc. 
No. : F07228) that met these criteria was used for further investiga- 
tion. 
I. Introduction 
Somatostatin peptides are widely distributed in central and 
peripheral tissues, participating in numerous and diverse phys- 
iological processes, including the regulation of GH and TSH 
secretion from the pituitary and the inhibition of secretion of 
gastrointestinal nd pancreatic hormones and enzymes [1]. 
The effects of somatostatin are mediated by G protein- 
coupled receptors (GPCR) that have affinity for both major 
peptide products of somatostatin gene expression, SS-14 and 
SS-28. Five different somatostatin receptors (SSTR) have been 
identified [2-4], each having a distinct pharmacological profile 
and distribution. These receptors are structurally similar and 
studies have revealed that each subtype has a characteristic 
pattern of tissue expression (reviewed in [5]). It has been sug- 
gested that the SSTR family may not be complete, and that 
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2.2. PCR amplification and genomic library screening 
As the EST fragment identified from the computerized database 
searches was unavailable from the IMAGE consortium, human geno- 
mic DNA was amplified using the polymerase chain reaction (PCR) 
using a set of specific oligonucleotides designed based on the EST 
cDNA sequence (P1 : 5'-CGGAATTCCTGGGCATCATCGG- 
GAACTC CACG; P2: 5'- CGTCTAGACAGGAGGCAGATCAC- 
CAGGGTGGC). Each primer contained a self-inserted restriction 
enzyme recognition sequence (EcoRI for P1 and XbaI for P2) to 
facilitate subcloning. The PCR conditions were as follows: denatura- 
tion at 94°C for 1 min, annealing at 55°C for 2 min and extension at 
72°C for 2 min for 30 cycles, followed by a 7 min extension at 72°C 
[10]. The resultant PCR products were phenol/chloroform extracted, 
precipitated with ethanol, phosphorylated with T4 polynucleotide ki- 
nase, and blunt-ended with Klenow enzyme [11]. Subsequently, they 
were electrophoresed on a 0.5% low-melting point agarose and a 
fragment of the expected size was subcloned into the EcoRV site of 
pBluescript SK(--) (pB/S; Stratagene, La Jolla, CA). Colonies were 
selected, plasmid DNA was purified, and the inserts sequenced. An 
insert identical in overlapping sequence with the EST cDNA was 
purified, radiolabeled with [c~-a2P]dCTP (NEN, Boston, MA) by 
nick translation (Amersham, Arlington Heights, IL) and used to 
screen a EMBL3 SP6/T7 human genomic library (Clontech, Palo 
Alto, CA). Positive phage clones were plaque purified and DNA 
was prepared. Following restriction digestion, the DNA was electro- 
phoresed on an agarose gel, transferred to nylon membrane, and 
hybridized with the same probe used to screen the library, as de- 
scribed by Marchese t al. [12]. 
All rights reserved. 
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2.3. PCR amplification of rat orthologue 
Rat genomic DNA was PCR-amplified using degenerate oligonu- 
cleotides designed based on the sequence encoding putative TM3 (P3 : 
5'-CTGACCGYCATGRSCATTGAC SGCTAC; Y = C or T, R = A 
or G, S = C or G) and TM7 (P4: 5'-GGGGTrGRSGCAGCTGTT- 
GGCRTA) of the receptor encoded by SLC-1 and somatostatin 
receptors. The PCR conditions were as follows: denaturation at 
95°C for 1 min, annealing at 55°C for 1 min and extension at 72°C 
for 2.5 rain for 30 cycles, followed by a 7 min extension at 72°C. The 
resultant PCR products were subcloned and sequenced as described 
earlier. 
2.4. Northern blot analysis 
RNA from several human tissues was extracted as previously de- 
scribed [12]. Briefly, total RNA was extracted by the method of 
Chomczynski and Sacchi [13], and poly(A) + RNA was isolated using 
oligo-dT cellulose spin columns (Pharmacia, Sweden). RNA was de- 
natured, size fractionated on a 1% formaldehyde agarose gel, and 
transferred onto nylon membrane and immobilized by UV irradiation. 
The blots were hybridized with a 855 bp 32P-labeled fragment of SLC- 
1 obtained from a PstI digestion, washed with 2× SSPE and 0.1% 
SDS at 50°C for 20 min and with 0.1 × SSPE and 0.1% SDS at 50°C 
for 2 h and exposed to X-ray film at -70°C in the presence of an 
intensifying screen for 1 week. Northern analysis of rat mRNA was 
done similarly using a radiolabelled rat orthologue of SLC-1. 
2.5. In situ hybridization analysis 
The PCR-derived rat orthologue of SLC-1 was used as a probe for 
in situ hybridization. Preparation of rat brain sections and in situ 
hybridization procedures were done as described [14]. 
2.6. Receptor expression and function 
A 1.6 kb SacI fragment containing SLC-1 was subcloned into the 
expression vector pcDNA3 (Invitrogen, San Diego, CA). This con- 
struct, named Phage 8-CA, contained 400 bp 5'-UTR. However, 121 
bp upstream of the start codon, a (CA)n tandem repeat sequence was 
present. A second construct, named Phage 8/SmaI, produced from a 
SmaI digest of the construct in pB/S, eliminated the CA repeat se- 
quence and reduced the 5'-UTR to 67 bp. This was also subcloned 
into pcDNA3 as described above. Transient expression of both con- 
structs was performed in COS-7 cells using a calcium phosphate rans- 
fection system (Gibco BRL, Gaithersburg, MD). Radioligand binding 
studies were carried out as described in Zastawny et al. [15]. Ligands 
used were [z25I]Tyr~-somatostatin-14, [3H]naloxone, [3H]bremazocine, 
[3H]DTG, and [3H]haloperidol (NEN, Boston, MA). 
2. 7. Chromosomal localization 
To determine which chromosome contained SLC-1, a monochro- 
mosomal somatic ell hybrid panel (Bios Laboratories; code #SCB- 
5500, blot #2931, enzyme EcoRI) consisting of human/hamster so- 
matic cell hybrids and human/mouse hybrids was hybridized over- 
night at 42°C with the same PCR fragment used to screen the genomic 
library. The panel was then washed first in 2 × SSC, 1% EDTA for 30 
min at 23°C followed by a final wash in 0.1 × SSC, 1% EDTA for 20 
min at 55°C. In a separate xperiment, to confirm the chromosomal 
assignment and to determine more specifically the locus of SLC-1, 
metaphase spread chromosomes derived from human lymphocytes 
were subjected to FISH and DAPI banding analyses. Slides were 
prepared and FISH was performed as previously described [16,17]. 
2.8. Dinucleotide repeat analysis 
Upon discovery of a dinucleotide repeat sequence of the form 
(CA)n, genomic DNA from 10 different human individuals was am- 
plified using oligonucleotides flanking the repeat sequence (P5: 5'- 
ACACTCAGGGCTACACATAGG; P6: 5'-TTCACTGTTGCTA 
ATCTTGTC). The resultant PCR products were subcloned and se- 
quenced as described earlier. 
2.9. Searching for subtypes 
Human genomic DNA was PCR-amplified using the degenerate 
oligonucleotides u ed to isolate the rat orthologue. The PCR condi- 
tions were as follows: denaturation at 95°C for 1 rain, annealing at 
either 55, 45 or 38°C for 1 min and extension at 72°C for 2.5 rain for 
30 cycles, followed by a 7 min extension at 72°C. The resultant PCR 
products were subcloned and sequenced. 
3. Results and discussion 
3.1. Cloning of  SLC-1 
Using an approach we used to clone novel GPCR genes 
GPR19 [14], GPR21 and GPR22 [18], we searched a dbEST 
for other GPCR-encoding sequences. The sequence of one 
EST eDNA fragment partially encoded a GPCR from TM1 
to TM3 which demonstrated significant identity to the soma- 
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Fig. 1. Amino acid comparison of the receptor encoded by SLC-1 with related somatostatin receptors, SSTRI to SSTR5. Amino acids identical 
with the protein encoded by SLC-1 are boxed and shaded. The predicted seven-transmembrane domains are indicated. Gaps ( - )  have been in- 
troduced to maximize the alignments among the sequences. 
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Fig. 2. Northern blot analyses of the brain distribution of SLC-1 mRNA in: (A) human and (B) rat. The human blot was probed with a frag- 
ment isolated from the coding region of SLC-1 and the rat blot probed with the rat orthologue of SLC-1. Each lane contained 5 gg of poly- 
(A) + RNA. 
tostatin receptors. We cloned a 350 bp genomic DNA frag- 
ment amplified from PCR using specific oligonucleotides n- 
compassing the published EST cDNA sequence. This frag- 
ment was used to screen a human genomic library to obtain 
the full-length open reading frame. Eight positive phage 
clones were isolated, purified and DNA prepared. Following 
restriction enzyme digestion and Southern blot analysis, a 1.6- 
kb SacI fragment from one phage (phage #8) was isolated, 
sequenced, and found to contain identical overlapping 
sequence to the EST cDNA. This genomic clone, named 
SLC-1 (aka GPR24), contained a full-length and intron- 
less open reading frame of 1206 bp encoding for a protein 
of 402 amino acids. Using BLAST search [6], highest identity 
was observed with the somatostatin receptor gene family. 
The receptor encoded by SLC-1 shares ~,0% identity with 
the SSTRs in the TM domains (Fig. 1). Significantly, an as- 
partic acid residue (AsplZ2; see Fig. 1) is present in TM3 
that aligns with the somatostatin receptors. It has been 
demonstrated in other GPCRs that this residue in the 
analogous position is important for receptor-ligand interac- 
tion [19-21]. The receptor encoded by SLC-1 has other 
residues considered to form the ligand binding pocket of 
SSTRs, namely Tyr 23°, Phe 266, Trp 31s, Tyr 322, and Gln 32S 
[5]. Compared with other SSTRs, the receptor encoded 
by SLC-1 has a large amino terminus and a short cytoplas- 
mic tail with no putative N-linked glycosylation sites identi- 
fied. 
Using PCR with oligonucleotides based on the sequence 
encoding TM3 and TM7 of the receptor encoded by SLC-1, 
we isolated the rat orthologue sequence. The protein sequence 
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Fig. 3. Darkfield autoradiograms of coronal sections of rat brain showing the localization of SLC-1 mRNA. Representative s ctions are shown 
at levels relative to bregma t (A) +0.7 mm and (B) -4.8 mm, according to the stereotactic coordinates [29]. Fr = frontoparietal cortex; Cg = an- 
terior cingulate cortex; SHi = septohippocampal nucleus; CPu = caudate putamen; Acb = nucleus accumbens; Tu = olfactory tubercle; PO = 
primary olfactory cortex; CA1, CA2, CA3 = fields of Amnon's horn; DG = dentate gyms; SN = substantia nigra pars compacta; PMCo = pos- 
teromedial cortical amygdaloid nucleus; LM = lateral mammillary nucleus; AHi = amygdalohippocampal area; Ent = entorhinal cortex. 
is highly conserved with only three amino acid differences 
(from a total of 157) between the human and rat. 
3.2. Dinucleotide repeat analysis 
Eighty base pairs upstream of the start codon is a repeat 
sequence of the form (CA)n. To determine the variabil ity in 
the length of this sequence, DNA samples from 10 individuals 
were amplified by PCR using oligonucleotides flanking the 
repeat sequence. Five individuals had homozygous repeat se- 
quences of n = 12, three individuals n = 10, one n = 11 and one 
individual was heterozygous with n = 13 and n = 11. 
3.3. Northern and in situ analyses 
Northern blot analysis detected a single 2.4 kb mRNA spe- 
cies for SLC-1 (in order of  decreasing abundance) in human 
frontal cortex, hypothalamus, basal forebrain, midbrain, 
amygdala, hippocampus, subthalamus, ubstantia nigra, thal- 
amus, corpus callosum, liver and heart, while no signals were 

















Fig. 4. FISH analysis of SLC-1. (A) Demonstrates the results of 
metaphase spread chromosomes probed with a phage clone encod- 
ing SLC-1. Arrows point to the FISH signals on a pair of chromo- 
somes. (B) A summary of the FISH analysis, each dot represents 
the location of a fluorescent signal on the chromosome using phage 
SLC-I as a probe. 
detected in the caudate-putamen, pancreas, kidney, muscle, 
lung, or placenta (selected regions are shown in Fig. 2A). 
Northern blot analysis of rat brain regions howed transcripts 
expressed (in order of decreasing abundance) in frontal cortex, 
striatum, cortex, thalamus, and pons (Fig. 2B), while no hy- 
bridizing signals were detected in the cerebellum. Analysis of 
rat peripheral tissues revealed that SLC-1 is expressed in (in 
order of decreasing abundance) kidney, ovary, fetus, and 
heart (data not shown). 
Using in situ hybridization of rat brain sections, the distri- 
bution of SLC-1 mRNA was found to be discretely localized 
to many areas (Fig. 3A,B). In cerebral cortex, signal was 
present in the anterior cingulate, frontal, piriform, and soma- 
tosensory areas. Dense labeling was present in the septohip- 
pocampal nucleus, which may be a component of the primor- 
dial hippocampus. Very dense labeling was detected in the 
olfactory tubercle, islands of Calleja, medial nucleus accum- 
bens, the dentate gyrus and the hippocampal reas CA1, CA2, 
and CA3. mRNA was also detected in moderate abundance in 
the lateral mammillary and tuberomammillary nuclei, amyg- 
daloid nuclei and the entorhinal area. Lesser amounts of 
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SLC-1 mRNA were visualized in claustrum, substantia nigra 
pars compacta, central grey, lateral geniculate nucleus, sub- 
parafascicular nucleus of thalamus, caudate putamen and nu- 
cleus accumbens. 
3.4. Pharmacological characterization of the receptor encoded 
by SLC-1 
A fragment encoding SLC-1 (having -400 bp of 5'-UTR) 
was inserted into pcDNA3 and transiently expressed in COS-7 
cells. A second construct was also used in which the CA 
tandem repeat element had been removed (67 bp of 5'- 
UTR). No specific binding was observed with [125I]Tyrl-so - 
matostatin-14 with either construct. Opioid and sigma ligands 
were also assayed for binding, however, [3H]naloxone, 
[3H]bremazocine, [3H]DTG, and [3H]haloperidol failed to 
show specific binding. 
3.5. Chromosomal ssignment 
A monochromosomal somatic ell hybrid panel was probed 
with the same PCR fragment used to screen a human genomic 
library. Only the lane corresponding to chromosome 22 dis- 
played two hybridizing bands (data not shown), indicating 
SLC-1 was located on chromosome 22. To localize SLC-1 
specifically on this chromosome, FISH analysis of human 
metaphase spread chromosomes in combination with DAPI 
banding patterns was used (Fig. 4A,B) [18]. SLC-1 is located 
at human chromosome 22, region q13.3. It is noteworthy that 
SSTR3 is located nearby at q13.1 [22]. 
3.6. Subtype search 
To search for other related genes, we used PCR to amplify 
genomic DNA with oligonucleotides based on SLC-1 and 
other somatostatin receptor genes. PCR fragments obtained 
using a 55°C annealing temperature yielded fragments identi- 
cal to SLC-1 (13 samples of 60), GPR7 (13) [23], SSTR2 (5) 
SSTR5 (4), SSTR3 (1), GPR14 (1) [24], bradykinin B2 recep- 
tor (1) [25], and non-GPCR encoding fragments (4). Two 
novel genes encoding for partial novel GPCR were identified, 
clone 37, showing high identity to GPR15 [26] and clone 42, 
to the galanin receptor [27]. An annealing temperature of 
45°C produced fragments identical to SLC-1 (36 of 94), 
GPR7 (22), SSTR5 (15), SSTR3 (6), clone 37 (4), clone 42 
(2), GPR14 (1), and 5 non-GPCR encoding fragments. An- 
nealing at 38°C gave fragments identical to SSTR3 (6 of 30), 
SSTR5 (5), GPR7 (5), SLC-1 (1), SSTR4 (1), GPR14 (1), and 
10 non-GPCR encoding fragments. One fragment encoded for 
a GPCR closest o the rat olfactory receptor-like protein I7 
[28] sharing 56% amino acid identity. 
In summary, we have isolated a novel human gene encoding 
a GPCR with significant homology to the somatostatin recep- 
tors that does not bind somatostatin. The abundance of SLC- 
1 mRNA expression in brain with regional ocalization to 
discrete areas involved in functions uch as emotion, memory 
and sensory perception make the isolation of the endogenous 
ligand of this receptor an important priority. This heralds the 
exciting potential of identifying a novel peptidergic neuro- 
transmitter signalling system in brain. 
Acknowledgements." This research was supported by grants from the 
National Institutes of Drug Abuse, the Medical Research Council of 
Canada, and the Smokeless Tobacco Research Council to B.F.O. and 
S.R.G. and was supported in part by a grant from UTHSCSA Re- 
search Resources Program for Medical Schools from the Howard 
258 L.F Kolakowski Jr. et al./FEBS Letters 398 (1996) 253-258 
Hughes Medical Institue to L.F.K. We would like to thank Victor 
Saldivia, Yang Shen, and Jenny Casares for their excellent echnical 
assistance. 
References 
[1] Schusdziarra, V. (1992) in: Basic and Clinical Aspects of Neu- 
roscience (Weil, C., Mfiller, E.E., and Thorner, M.O. eds.), So- 
matostatin, Vol. 4, pp. 43-54, Springer, Heidelberg. 
[2] Yamada, Y., Post, S.R., Wang, K., Tager, H.S., Bell, G.I. and 
Seino, S. (1992) Proc. Natl. Acad. Sci. USA 89, 251-255. 
[3] Corness, J.D., Demchyshyn, L.L, Seeman, P., Van Tol, H.H.M., 
Srikant, C.B., Kent, G., Patel, Y.C. and Niznik, H.B. (1993) 
FEBS Lett. 321,279-284. 
[4] Yamada, Y., Kagimoto, S., Kubota, A., Yasuda, K., Masuda, 
K., Someya, Y., Ihara, Y., Li, Q., Imura, H., Seino, S. and Seino, 
Y. (1993) Biochem. Biophys. Res. Commun. 195, 844-852. 
[5] Patel, Y.C., Greenwood, M.T., Panetta, R., Demchyshyn, L., 
Niznik, H. and Srikant, C.B. (1995) Life Sci. 57, 1249-1265. 
[6] Altschul, S.F., Gish, W., Miller, W., Myers, E.W. and Lipman, 
D.J. (1990) J. Mol. Biol. 215, 403-410. 
[7] Pearson, W.R. and Lipman, D.J. (1988) Proc. Natl. Acad. Sci. 
USA 85, 2444-2448. 
[8] Pearson, W.R. (1995) Prot. Sci. 4, 1145-1160. 
[9] Kolakowski, L.F. (1994) Int. J. Receptors, Channels Transpor- 
ters 2, 1-7. 
[10] Nguyen, T., Erb, L., Weisman, G.A., Marchese, A., Heng, 
H.H.Q., Garrad, R.C., George, S.R., Turner, J.T., and O'Dowd, 
B.F. (1995) J. Biol. Chem. 270, 30845-30848. 
[11] Jin, H., Oksenberg, D., Ashkenazi, A., Peroutka, S.J., Duncan, 
A.M.V., Rozmahel, R., Yang, Y., Mengod, G., Palacios, J.M,, 
and O'Dowd, B.F. (1992) J. Biol. Chem. 267, 5735-5738. 
[12] Marchese, A., Docherty, J.M., Nguyen, T., Heiber, M., Cheng, 
R., Heng, H.H.Q., Tsui, L.-C., Shi, X., George, S.R. and 
O'Dowd, B.F. (1994) Genomics 23, 609 618. 
[13] Chomczynski, P. and Sacchi, N. (1987) Anal. Biochem. 162, 156- 
159. 
[14] O'Dowd, B.F., Nguyen, T., Lynch, K.R., Kolakowski, F.L., 
Thompson, M., Cheng, R., Marchese, A., Ng, G., Heng, 
H.H.Q. and George, S.R. (1996) FEBS Lett. 394, 325 329. 
[15] Zastawny, R.L., George, S.R., Nguyen, T., Cheng, R., Tsatsos, 
J., Briones-Urbina, R. and O'Dowd B.F. (1994) J. Neurochem. 
62, 2099-2105. 
[16] Heng, H.H.Q., Squire, J. and Tsui, L.-C. (1992) Proc. Natl. 
Acad. Sci. USA 89, 9509-9513. 
[17] Heng, H.H.Q. and Tsui, L.-C. (1993) Chromosoma 102, 325-332. 
[18] O'Dowd, B.F., Nguyen, T., Jung, B.P., Marchese, A., Cheng, R., 
Heng, H.H.Q., Kolakowski, L.F., Lynch, K.R. and George, S.R. 
(1997) Gene, in press. 
[19] Strader, C.D., Sigal, I.S., Register, R.B., Candelore, M.R., 
Rands, E. and Dixon, R.A.F. (1987) Proc. Natl. Acad. Sci. 
USA 84, 4384-4388. 
[20] Fraser, C.D., Wang, C.D., Robinson. D.A., Gocayne, J.D. and 
Venter, J.C. (1989) Mol. Pharmacol. 36, 840-847. 
[21] Surrat, C.K., Johnson, P.S., Moriwaki, A., Sidleck, B.K., Blas- 
chak, C.J., Wang, J.B. and Uhl, G.R. (1994) J. Biol. Chem. 269, 
20548-20553. 
[22] Yamada, Y., Stoffel, M., Espinosa III, R., Xiang, K.-S., Seino, 
M., Seino, S., Le Beau, M.M. and Bell, G.I. (1993) Genomics 15, 
449-452. 
[23] O'Dowd, B.F., Scheideler, M.A., Nguyen, T., Cheng, R., Ras- 
mussen, J.S., Marchese, A., Zastawny, R., Heng, H.H.Q., Tsui, 
L.-C., Shi, Xiaomei, S., Puy, L. and George, S.R. (1995) Genom- 
ics 28, 84-91. 
[24] Marchese, A., Heiber, M., Nguyen, T., Heng, H.H.Q., Saldivia, 
V.R., Cheng, R., Murphy, P.M., Tsui, L.-C., Shi, X., Gregor, P., 
George, S.R., O'Dowd, B.F. and Docherty, J.M. (1994) Genom- 
ics 29, 335 344. 
[25] Powell, S.J., Slynn, G., Thomas, C., Hopkins, B., Briggs, I. and 
Graham, A. (1993) Genomics 15, 435-438. 
[26] Heiber, M., Marchese, A., Nguyen, T., Heng, H.H.Q., George, 
S.R. and O'Dowd, B.F. (1996) Genomics 32, 462-465. 
[27] Habert-Ortoli, E., Amiranoff, B., Loquet, I., Laburthe, M. and 
Mayaux, J.-F. (1994) Proc. Natl. Acad. Sci. 91,978~9783. 
[28] Buck, L. and Axel, R. (1991) Cell 65, 175 187. 
[29] Paxinos, G. and Watson, C. (1982) The Rat Brain, Academic 
Press, New York. 
